LENZETTO is a transdermal spray formulation of estradiol, a type of estrogen hormone therapy used primarily in the management of menopausal symptoms in women. It is designed to deliver estradiol through the skin directly into the bloodstream, providing an alternative to oral or patch methods of hormone replacement therapy (HRT). LENZETTO is specifically indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause, such as hot flashes and night sweats, as well as for the prevention of osteoporosis in postmenopausal women. The spray application allows for a convenient and controlled dosing, aiming to mimic the body's natural estrogen levels more closely and potentially reducing the risk of side effects associated with traditional HRT methods.